By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Spectrum Pharmaceuticals, Inc. 

157 Technology Drive

Irvine  California  92618  U.S.A.
Phone: 949-788-6700 Fax: 949-788-6706


SEARCH JOBS


Industry
Pharmaceutical

Segment
Oncology





Company News
Spectrum Pharma (SPPI) Settles FOLOTYN (Pralatrexate Injection) ANDA Patent Litigation 7/13/2016 9:41:32 AM
Spectrum Pharma (SPPI) To Present Corporate Update At The Cantor Fitzgerald’s 2nd Annual Healthcare Conference On July 13th 7/6/2016 9:11:19 AM
Spectrum Pharma (SPPI) To Present Corporate Update At The Jefferies 2016 Healthcare Conference On June 8th 6/1/2016 5:00:39 PM
Spectrum Pharma (SPPI) Highlights An Oral Presentation On Apaziquone At The 2016 Annual Meeting Of The American Urological Association Education And Research Inc. (AUA) In San Diego, California, May 6-10, 2016 5/6/2016 9:13:25 AM
Spectrum Pharma (SPPI) Reports First Quarter 2016 Financial Results And Pipeline Update 5/6/2016 8:55:33 AM
Spectrum Pharma (SPPI) To Present Corporate Update At The Bank of America (BAC) Merrill Lynch 2016 Healthcare Conference On May 10th 5/3/2016 11:17:34 AM
Spectrum Pharma (SPPI) Announces First Quarter 2016 Financial Results Teleconference And Webcast 4/28/2016 11:14:34 AM
Spectrum Pharma (SPPI) Release: FDA Grants Orphan Drug Exclusivity To EVOMELA (melphalan) For Injection, Indicated For Multiple Myeloma 4/20/2016 11:36:52 AM
Ligand (LGND) Partner Spectrum Pharma (SPPI) Receives FDA Approval Of EVOMELA (Melphalan) For Injection 3/15/2016 10:49:35 AM
FDA Grants Spectrum Pharma (SPPI) Approval Of EVOMELA (Melphalan) For Injection 3/15/2016 10:31:41 AM
12345678910...
//-->